1 |
ELANE
| 2件: Transcriptional misregulation in cancer Transcriptional misregulation in cancer, Systemic lupus erythematosus | D03788
D03788
|
Sivelestat
| 3件: 13 13, 85, 96 |
2 |
GRIN2A
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D00775
D00775
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
3 |
GRIN2A
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D03742
D03742
|
Dextromethorphan
| 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
4 |
GRIN2A
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D07058
D07058
|
Acamprosate
| 2件: 6 6, 206 |
5 |
GRIN2A
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D07283
D07283
|
Esketamine
| 3件: 2 2, 4, 70 |
6 |
GRIN2A
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D07441
D07441
|
Amantadine
| 4件: 6 6, 8, 13, 127 |
7 |
GRIN2A
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D08098
D08098
|
Ketamine
| 8件: 2 2, 4, 6, 13, 70, 113, 156, 215 |
8 |
GRIN2A
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D08174
D08174
|
Memantine
| 8件: 2 2, 6, 8, 13, 49, 127, 205, 206 |
9 |
GRIN2A
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D09917
D09917
|
Latrepirdine
| 1件: 8 8 |
10 |
GRIN2B
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D00775
D00775
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
11 |
GRIN2B
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D03742
D03742
|
Dextromethorphan
| 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
12 |
GRIN2B
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D07058
D07058
|
Acamprosate
| 2件: 6 6, 206 |
13 |
GRIN2B
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D07283
D07283
|
Esketamine
| 3件: 2 2, 4, 70 |
14 |
GRIN2B
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D07441
D07441
|
Amantadine
| 4件: 6 6, 8, 13, 127 |
15 |
GRIN2B
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D08098
D08098
|
Ketamine
| 8件: 2 2, 4, 6, 13, 70, 113, 156, 215 |
16 |
GRIN2B
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D08174
D08174
|
Memantine
| 8件: 2 2, 6, 8, 13, 49, 127, 205, 206 |
17 |
GRIN2B
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D09917
D09917
|
Latrepirdine
| 1件: 8 8 |
18 |
IFNG
| 8件: TGF-beta signaling pathway TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D04242
D04242
|
Fontolizumab
| 1件: 46 46 |
19 |
IFNG
| 8件: TGF-beta signaling pathway TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D11120
D11120
|
Emapalumab
| 3件: 49 49, 65, 107 |
20 |
IL10
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, T cell receptor signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D01583
D01583
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
21 |
TNF
| 11件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D00742
D00742
|
Etanercept
| 16件: 15 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 |
22 |
TNF
| 11件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D00754
D00754
|
Thalidomide
| 20件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
23 |
TNF
| 11件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D01583
D01583
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
24 |
TNF
| 11件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D02597
D02597
|
Adalimumab
| 17件: 19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 |
25 |
TNF
| 11件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D02598
D02598
|
Infliximab
| 27件: 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 |
26 |
TNF
| 11件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D03441
D03441
|
Certolizumab pegol
| 8件: 37 37, 46, 49, 96, 97, 107, 226, 271 |
27 |
TNF
| 11件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D04358
D04358
|
Golimumab
| 8件: 46 46, 56, 84, 96, 97, 107, 270, 271 |
28 |
TNF
| 11件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D04687
D04687
|
Lenalidomide
| 8件: 16 16, 26, 28, 34, 49, 284, 300, 331 |
29 |
TNF
| 11件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D05393
D05393
|
Pegsunercept
| 1件: 46 46 |
30 |
TNF
| 11件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D08976
D08976
|
Pomalidomide
| 5件: 28 28, 51, 85, 227, 331 |
31 |
TNF
| 11件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D09944
D09944
|
Ozoralizumab
| 1件: 46 46 |
32 |
C1R
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D10845
D10845
|
Conestat alfa
| 1件: 61 61 |
33 |
C1S
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D10845
D10845
|
Conestat alfa
| 1件: 61 61 |
34 |
C1S
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D11530
D11530
|
Sutimlimab
| 1件: 61 61 |
35 |
C3
| 3件: Tuberculosis Tuberculosis, Viral carcinogenesis, Systemic lupus erythematosus | D11613
D11613
|
Pegcetacoplan
| 4件: 2 2, 61, 62, 222 |
36 |
C5
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D03940
D03940
|
Eculizumab
| 7件: 11 11, 13, 14, 61, 62, 109, 222 |
37 |
C5
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D11054
D11054
|
Ravulizumab
| 7件: 2 2, 11, 13, 50, 62, 66, 109 |
38 |
C5
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D11473
D11473
|
Nomacopan
| 3件: 62 62, 109, 162 |
39 |
C5
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D11477
D11477
|
Pozelimab
| 2件: 11 11, 62 |
40 |
C5
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D11696
D11696
|
Crovalimab
| 2件: 62 62, 109 |
41 |
C5
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D11838
D11838
|
Vilobelimab
| 3件: 43 43, 44, 269 |
42 |
C5
| 1件: Systemic lupus erythematosus Systemic lupus erythematosus | D12357
D12357
|
Zilucoplan
| 3件: 2 2, 11, 62 |
43 |
CD80
| 5件: Virion - Adenovirus Virion - Adenovirus, Toll-like receptor signaling pathway, Type I diabetes mellitus, Systemic lupus erythematosus, Viral myocarditis | D03203
D03203
|
Abatacept
| 26件: 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 |
44 |
CD80
| 5件: Virion - Adenovirus Virion - Adenovirus, Toll-like receptor signaling pathway, Type I diabetes mellitus, Systemic lupus erythematosus, Viral myocarditis | D03222
D03222
|
Belatacept
| 1件: 46 46 |
45 |
CD86
| 6件: Virion - Adenovirus Virion - Adenovirus, Toll-like receptor signaling pathway, Type I diabetes mellitus, Transcriptional misregulation in cancer, Systemic lupus erythematosus, Viral myocarditis | D03203
D03203
|
Abatacept
| 26件: 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 |
46 |
CD86
| 6件: Virion - Adenovirus Virion - Adenovirus, Toll-like receptor signaling pathway, Type I diabetes mellitus, Transcriptional misregulation in cancer, Systemic lupus erythematosus, Viral myocarditis | D03222
D03222
|
Belatacept
| 1件: 46 46 |
47 |
CD40
| 5件: Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Systemic lupus erythematosus, Viral myocarditis | D11357
D11357
|
Bleselumab
| 1件: 222 222 |
48 |
CD40
| 5件: Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Systemic lupus erythematosus, Viral myocarditis | D11597
D11597
|
Ravagalimab
| 2件: 53 53, 97 |
49 |
CD40
| 5件: Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Systemic lupus erythematosus, Viral myocarditis | D11610
D11610
|
Iscalimab
| 2件: 49 49, 53 |
50 |
CD40LG
| 4件: T cell receptor signaling pathway T cell receptor signaling pathway, Toxoplasmosis, Systemic lupus erythematosus, Viral myocarditis | D06193
D06193
|
Toralizumab
| 1件: 63 63 |